Optimisation of antimicrobial therapy using pharmacokinetic and pharmacodynamic parameters

Clinical Microbiology and Infection

Volumn 7, Issue 11, 2001, Pages 589-596

  Jacobs, M R ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Haemophilus influenzae; Otitis media; Pharmacodynamics; Pharmacokinetics; Respiratory tract infection; Streptococcus pneumoniae

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFACLOR; CEFEPIME; CEFIXIME; CEFOTAXIME; CEFPROZIL; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; LEVOFLOXACIN; LORACARBEF; MACROLIDE; MEROPENEM; MONOBACTAM DERIVATIVE; PENICILLIN DERIVATIVE; PENICILLIN G; PLACEBO; QUINOLONE DERIVATIVE;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; AREA UNDER THE CURVE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DOSE RESPONSE; DOSIMETRY; DRUG BLOOD LEVEL; DRUG EFFICACY; HAEMOPHILUS INFLUENZAE; HUMAN; IMMUNE DEFICIENCY; MINIMUM INHIBITORY CONCENTRATION; OTITIS MEDIA; PHARMACODYNAMICS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; STREPTOCOCCUS PNEUMONIAE;

HAEMOPHILUS; HAEMOPHILUS INFLUENZAE; STREPTOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0035522312     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1198-743X.2001.00295.x     Document Type: Review

References (29)

1. Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men
2. Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins
3. Antimicrobial resistance issues of the future
4. Postantibiotic effects and dosing of macrolides, azalides, and streptogramins
5. Pharmacodynamics and pharmacokinetics of fluoroquinolones in experimental animals
6. Clinical significance of antibiotic resistance in acute otitis media and implication of antibiotic treatment on carriage and spread of resistant organisms
7. Bacteriologic and clinical efficacy of amoxicillin/clavulanate vs. azithromycin in acute otitis media
8. Sparfloxacin vs ofloxacin in the treatment of acute bacteria] exacerbations of chronic bronchitis: A multicenter, double-blind, randomized, comparative study
9. Acute otitis media: Management and surveillance in an era of pneumococcal resistance - A report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group
10. Relevance of pharmacokinetics and pharmacodynamics in the selection of antibiotics for respiratory tract infections
11. Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: Ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d
12. Community-acquired pneumonia in adults: Guidelines for management
13. Efficacy and tolerability of azithromycin versus amoxicillin/clavulanic acid in acute purulent exacerbation of chronic bronchitis
14. Microbiology and management of sinusitis
15. Overview of community acquired pneumonia. Prognosis and clinical features
16. Prognosis and outcomes of patients with community-acquired pneumonia
17. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
18. The etiology of respiratory tract infections and the antibacterial activity of fluoroquinolones and other oral antibacterial agents against respiratory pathogens
19. Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae
20. How do we achieve cost-effective options in lower respiratory tract infection therapy?
21. Results of the Alexander Project: A continuing, multicenter study of the antimicrobial susceptibility of community-acquired lower respiratory tract bacterial pathogens
22. Efficacy of amoxicillin/clavulanate for acute otitis media: Relation to Streptococcus pneumoniae susceptibility
23. Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 US surveillance study
24. Measuring the comparative efficacy of antibacterial agents for acute otitis media: The 'Polyanna phenomenon'
25. Prospective development of pharmacodynamic relationships between measures of levofloxacin exposure and measures of patient outcome
26. Antimicrobial Treatment Guidelines for Acute Bacterial Rhinosinusitis
27. Randomized, double-blind study of ciprofloxacin and cefuroxime axetil for treatment of acute bacterial exacerbations of chronic bronchitis
28. Efficacy of oral ciprofloxacin vs. clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis
29. Pharmacokinetics and pharmacodynamics of fluoroquinolones